Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pitchai Balakumar

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Pharmacology & Therapeutics|March 7, 2026
Insights into effective protocol structuring: optimizing dosing strategies, experimental design, and statistical approachesPitchai Balakumar, Krishnadas Nandakumar, Gowraganahalli Jagadeesh
Cardiovascular Toxicology|December 5, 2012
Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signalsGaurav Taneja, Nanjaian Mahadevan, Pitchai Balakumar
Current Molecular Pharmacology|January 15, 2019
A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic DyslipidemiaPitchai Balakumar, Nanjaian Mahadevan, Ramanathan Sambathkumar
Toxicology|February 5, 2008
Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directionsPitchai Balakumar, Tajpreet Kaur, Manjeet Singh
Pharmacological Research|July 1, 2008
Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?Pitchai Balakumar, Ankur Rohilla, Manjeet Singh
Pharmacological Research|May 4, 2010
Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?Pitchai Balakumar, Ankur Rohilla, Arunachalam Thangathirupathi
Cellular Signalling|April 24, 2012
How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?Gowraganahalli Jagadeesh, Pitchai Balakumar, Norman Stockbridge
European Journal of Pharmacology|March 30, 2010
The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathyMandeep Kumar Arora, Krishna Reddy, Pitchai Balakumar
International Journal of Cardiology|February 6, 2014
Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in ratsArun Kumar Sharma, Deepa Khanna, Pitchai Balakumar
Journal of Pharmacological and Toxicological Methods|March 30, 2007
Rodent models of heart failurePitchai Balakumar, Amrit Pal Singh, Manjeet Singh
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Pharmacology & Therapeutics|March 7, 2026
Insights into effective protocol structuring: optimizing dosing strategies, experimental design, and statistical approachesPitchai Balakumar, Krishnadas Nandakumar, Gowraganahalli Jagadeesh
Cardiovascular Toxicology|December 5, 2012
Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signalsGaurav Taneja, Nanjaian Mahadevan, Pitchai Balakumar
Current Molecular Pharmacology|January 15, 2019
A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic DyslipidemiaPitchai Balakumar, Nanjaian Mahadevan, Ramanathan Sambathkumar
Toxicology|February 5, 2008
Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directionsPitchai Balakumar, Tajpreet Kaur, Manjeet Singh
Pharmacological Research|July 1, 2008
Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?Pitchai Balakumar, Ankur Rohilla, Manjeet Singh
Pharmacological Research|May 4, 2010
Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?Pitchai Balakumar, Ankur Rohilla, Arunachalam Thangathirupathi
Cellular Signalling|April 24, 2012
How well do aliskiren's purported mechanisms track its effects on cardiovascular and renal disorders?Gowraganahalli Jagadeesh, Pitchai Balakumar, Norman Stockbridge
European Journal of Pharmacology|March 30, 2010
The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathyMandeep Kumar Arora, Krishna Reddy, Pitchai Balakumar
International Journal of Cardiology|February 6, 2014
Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in ratsArun Kumar Sharma, Deepa Khanna, Pitchai Balakumar
Journal of Pharmacological and Toxicological Methods|March 30, 2007
Rodent models of heart failurePitchai Balakumar, Amrit Pal Singh, Manjeet Singh
Pageof 10